The global Emergency Contraceptive Pills Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Combination pills, Progesterone pills, Ulipristal acetate), By Distribution Channel (Retail Store, Online Store, Others)
In 2025, the market for emergency contraceptive pills (ECPs) continues to play a crucial role in reproductive healthcare, offering women a safe and effective option for preventing unintended pregnancies following unprotected intercourse or contraceptive failure. ECPs, also known as morning-after pills, contain hormones such as levonorgestrel or ulipristal acetate, which work by preventing ovulation, fertilization, or implantation of the fertilized egg in the uterus. With increasing awareness of sexual health and reproductive rights, women are increasingly turning to ECPs as a backup contraceptive method in case of emergencies. Moreover, advancements in ECP formulations, such as single-dose regimens and over-the-counter availability, enhance accessibility and convenience, allowing women to obtain timely and discreet access to emergency contraception when needed. Additionally, initiatives promoting sexual education, access to contraception, and reproductive healthcare services contribute to reducing unintended pregnancies and empowering women to make informed choices about their reproductive health. As reproductive health remains a priority for women worldwide, the market for emergency contraceptive pills presents opportunities for education, advocacy, and collaboration between healthcare providers, policymakers, and pharmaceutical companies to ensure access to safe and effective emergency contraception and promote sexual health equity.
The market report analyses the leading companies in the industry including Afaxys Pharma LLC, Bayer AG, Combe Inc, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd, Knoll Healthcare Pvt. Ltd, Laboratoire HRA Pharma SAS, Lupin Ltd, Mankind Pharma Ltd, Morepen Laboratories Ltd, Perrigo Co. Plc, Pfizer Inc, Piramal Enterprises Ltd, Sun Pharmaceutical Industries Ltd, Syzygy Healthcare LLC, Teva Pharmaceutical Industries Ltd, and Others.
A significant trend in the emergency contraceptive pills market is the increased accessibility and awareness of emergency contraception. With growing efforts to promote reproductive health education, expand access to contraceptives, and reduce unintended pregnancies, there is a rising awareness among individuals about the availability and effectiveness of emergency contraceptive pills as a backup option for preventing pregnancy after unprotected intercourse or contraceptive failure. This trend is driven by factors such as advocacy for reproductive rights, government initiatives to improve access to reproductive healthcare services, and the influence of social media and digital platforms in disseminating information about emergency contraception. Additionally, the availability of emergency contraceptive pills over-the-counter in many countries without a prescription further enhances accessibility and empowers individuals to make informed decisions about their reproductive health. As a result, there is an increasing acceptance and utilization of emergency contraceptive pills as an important tool for preventing unplanned pregnancies and supporting reproductive autonomy.
A key driver behind the demand for emergency contraceptive pills is the need for timely and effective pregnancy prevention in situations where traditional contraceptive methods have failed or were not used. Unplanned pregnancies can occur due to various reasons such as contraceptive failure, inconsistent or incorrect use of contraceptives, sexual assault, or unexpected changes in contraceptive plans. In such instances, emergency contraceptive pills offer a crucial option for individuals to prevent pregnancy when faced with an urgent need for contraception. This driver is fueled by factors such as the desire to avoid unintended pregnancies, concerns about the emotional, social, and financial implications of an unplanned pregnancy, and the importance of reproductive autonomy and decision-making. Emergency contraceptive pills provide a safe and reliable way to prevent pregnancy when taken within a specific timeframe after unprotected intercourse, offering peace of mind and reassurance to individuals seeking immediate pregnancy prevention.
An opportunity for the emergency contraceptive pills market lies in expansion into telemedicine and remote access services to improve convenience, accessibility, and privacy for individuals seeking emergency contraception. Manufacturers and healthcare providers can explore opportunities to offer teleconsultations, online prescriptions, and discreet delivery services for emergency contraceptive pills, enabling individuals to access contraception from the comfort and privacy of their homes. By leveraging telemedicine platforms and digital health technologies, providers can reach underserved populations, rural communities, and individuals with limited access to traditional healthcare facilities, expanding the reach and impact of emergency contraception services. Additionally, offering online resources, educational materials, and support networks for individuals seeking information about emergency contraception enhances awareness, reduces stigma, and empowers informed decision-making about reproductive health options. Furthermore, partnering with telemedicine providers, pharmacies, and advocacy organizations to promote telehealth initiatives and advocate for policy changes that support remote access to emergency contraception presents opportunities to advance reproductive health equity and improve outcomes for individuals seeking timely and discreet pregnancy prevention solutions. By embracing innovation and technology in service delivery, the emergency contraceptive pills market can enhance accessibility, affordability, and convenience for individuals seeking reproductive healthcare services, ultimately contributing to improved reproductive health outcomes and empowerment.
In the Emergency Contraceptive Pills Market segmented by type, combination pills emerge as the largest segment, driven by their widespread availability, efficacy, and familiarity among healthcare providers and consumers. Combination pills contain a combination of estrogen and progestin hormones, which work together to prevent ovulation and inhibit fertilization, thus reducing the risk of unintended pregnancy. This established method of emergency contraception is widely recognized and recommended by healthcare professionals, contributing to its dominance in the market. Additionally, combination pills are available over-the-counter in many regions, making them easily accessible to women seeking emergency contraception without a prescription. The convenience and reliability of combination pills, coupled with their proven effectiveness, solidify their position as the largest segment in the Emergency Contraceptive Pills Market.
In the Emergency Contraceptive Pills Market segmented by distribution channel, the online store segment is experiencing rapid growth, driven by several factors. The convenience, anonymity, and accessibility offered by online platforms make them increasingly popular channels for purchasing emergency contraceptive pills. Women seeking emergency contraception often prefer the discretion and privacy afforded by online shopping, allowing them to access these products discreetly and without judgment. Additionally, the proliferation of e-commerce platforms and the rise of telehealth services have made it easier for women to obtain emergency contraceptive pills online, especially in regions where access to reproductive healthcare services may be limited. The ability to compare prices, read reviews, and access information about emergency contraception further contributes to the appeal of online stores. As consumers increasingly turn to online channels for their healthcare needs, the online store segment of the Emergency Contraceptive Pills Market is poised for continued rapid growth in the foreseeable future.
By Type
By Distribution Channel
Countries Analyzed
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Emergency Contraceptive Pills Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Emergency Contraceptive Pills Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Emergency Contraceptive Pills Market Share by Company, 2023
4.1.2. Product Offerings of Leading Emergency Contraceptive Pills Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Emergency Contraceptive Pills Market Drivers
6.2. Emergency Contraceptive Pills Market Challenges
6.6. Emergency Contraceptive Pills Market Opportunities
6.4. Emergency Contraceptive Pills Market Trends
Chapter 7. Global Emergency Contraceptive Pills Market Outlook Trends
7.1. Global Emergency Contraceptive Pills Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Emergency Contraceptive Pills Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Emergency Contraceptive Pills Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Combination pills
Progesterone pills
Ulipristal acetate
By Distribution Channel
Retail Store
Online Store
Others
Chapter 8. Global Emergency Contraceptive Pills Regional Analysis and Outlook
8.1. Global Emergency Contraceptive Pills Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Emergency Contraceptive Pills Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Emergency Contraceptive Pills Regional Analysis and Outlook
8.2.2. Canada Emergency Contraceptive Pills Regional Analysis and Outlook
8.2.3. Mexico Emergency Contraceptive Pills Regional Analysis and Outlook
8.3. Europe Emergency Contraceptive Pills Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Emergency Contraceptive Pills Regional Analysis and Outlook
8.3.2. France Emergency Contraceptive Pills Regional Analysis and Outlook
8.3.3. United Kingdom Emergency Contraceptive Pills Regional Analysis and Outlook
8.3.4. Spain Emergency Contraceptive Pills Regional Analysis and Outlook
8.3.5. Italy Emergency Contraceptive Pills Regional Analysis and Outlook
8.3.6. Russia Emergency Contraceptive Pills Regional Analysis and Outlook
8.3.7. Rest of Europe Emergency Contraceptive Pills Regional Analysis and Outlook
8.4. Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) by Country (2021-2032)
8.4.1. China Emergency Contraceptive Pills Regional Analysis and Outlook
8.4.2. Japan Emergency Contraceptive Pills Regional Analysis and Outlook
8.4.3. India Emergency Contraceptive Pills Regional Analysis and Outlook
8.4.4. South Korea Emergency Contraceptive Pills Regional Analysis and Outlook
8.4.5. Australia Emergency Contraceptive Pills Regional Analysis and Outlook
8.4.6. South East Asia Emergency Contraceptive Pills Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Emergency Contraceptive Pills Regional Analysis and Outlook
8.5. South America Emergency Contraceptive Pills Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Emergency Contraceptive Pills Regional Analysis and Outlook
8.5.2. Argentina Emergency Contraceptive Pills Regional Analysis and Outlook
8.5.3. Rest of South America Emergency Contraceptive Pills Regional Analysis and Outlook
8.6. Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Emergency Contraceptive Pills Regional Analysis and Outlook
8.6.2. Africa Emergency Contraceptive Pills Regional Analysis and Outlook
Chapter 9. North America Emergency Contraceptive Pills Analysis and Outlook
9.1. North America Emergency Contraceptive Pills Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Emergency Contraceptive Pills Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Emergency Contraceptive Pills Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Emergency Contraceptive Pills Revenue (USD Million) by Product (2021-2032)
By Type
Combination pills
Progesterone pills
Ulipristal acetate
By Distribution Channel
Retail Store
Online Store
Others
Chapter 10. Europe Emergency Contraceptive Pills Analysis and Outlook
10.1. Europe Emergency Contraceptive Pills Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Emergency Contraceptive Pills Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Emergency Contraceptive Pills Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Emergency Contraceptive Pills Revenue (USD Million) by Product (2021-2032)
By Type
Combination pills
Progesterone pills
Ulipristal acetate
By Distribution Channel
Retail Store
Online Store
Others
Chapter 11. Asia Pacific Emergency Contraceptive Pills Analysis and Outlook
11.1. Asia Pacific Emergency Contraceptive Pills Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) by Product (2021-2032)
By Type
Combination pills
Progesterone pills
Ulipristal acetate
By Distribution Channel
Retail Store
Online Store
Others
Chapter 12. South America Emergency Contraceptive Pills Analysis and Outlook
12.1. South America Emergency Contraceptive Pills Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Emergency Contraceptive Pills Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Emergency Contraceptive Pills Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Emergency Contraceptive Pills Revenue (USD Million) by Product (2021-2032)
By Type
Combination pills
Progesterone pills
Ulipristal acetate
By Distribution Channel
Retail Store
Online Store
Others
Chapter 13. Middle East and Africa Emergency Contraceptive Pills Analysis and Outlook
13.1. Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) by Product (2021-2032)
By Type
Combination pills
Progesterone pills
Ulipristal acetate
By Distribution Channel
Retail Store
Online Store
Others
Chapter 14. Emergency Contraceptive Pills Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Afaxys Pharma LLC
Bayer AG
Combe Inc
Foundation Consumer Healthcare LLC
Gedeon Richter Plc
HLL Lifecare Ltd
Knoll Healthcare Pvt. Ltd
Laboratoire HRA Pharma SAS
Lupin Ltd
Mankind Pharma Ltd
Morepen Laboratories Ltd
Perrigo Co. Plc
Pfizer Inc
Piramal Enterprises Ltd
Sun Pharmaceutical Industries Ltd
Syzygy Healthcare LLC
Teva Pharmaceutical Industries Ltd
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Emergency Contraceptive Pills Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Emergency Contraceptive Pills Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Emergency Contraceptive Pills Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Emergency Contraceptive Pills Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Emergency Contraceptive Pills Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Emergency Contraceptive Pills Market Share (%) By Regions (2021-2032)
Table 12 North America Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Table 15 South America Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) By Region (2021-2032)
Table 17 North America Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Table 18 North America Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Table 19 North America Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
Table 26 South America Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Table 27 South America Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Table 28 South America Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Emergency Contraceptive Pills Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Emergency Contraceptive Pills Market Share (%) By Regions (2023)
Figure 6. North America Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 12. France Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 12. China Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 14. India Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Emergency Contraceptive Pills Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Emergency Contraceptive Pills Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Emergency Contraceptive Pills Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Emergency Contraceptive Pills Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Emergency Contraceptive Pills Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Emergency Contraceptive Pills Revenue (USD Million) By Product (2021-2032)
By Type
By Distribution Channel
Countries Analyzed
The Global Emergency Contraceptive Pills Market Size is estimated at $741.5 Million in 2025 and is forecast to register an annual growth rate (CAGR) of 4.1% to reach $1064.6 Million by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Afaxys Pharma LLC, Bayer AG, Combe Inc, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd, Knoll Healthcare Pvt. Ltd, Laboratoire HRA Pharma SAS, Lupin Ltd, Mankind Pharma Ltd, Morepen Laboratories Ltd, Perrigo Co. Plc, Pfizer Inc, Piramal Enterprises Ltd, Sun Pharmaceutical Industries Ltd, Syzygy Healthcare LLC, Teva Pharmaceutical Industries Ltd
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume